Guruprasad P. Aithal

1999–2025 年に発表

165
論文数
29,047
被引用数
79
h 指数
157
i10 指数

被引用数

Guruprasad P. Aithal の年別被引用数1995 年: 被引用 2 件1999 年: 被引用 5 件2000 年: 被引用 13 件2001 年: 被引用 32 件2002 年: 被引用 28 件2003 年: 被引用 38 件2004 年: 被引用 30 件2005 年: 被引用 53 件2006 年: 被引用 47 件2007 年: 被引用 55 件2008 年: 被引用 77 件2009 年: 被引用 122 件2010 年: 被引用 152 件2011 年: 被引用 131 件2012 年: 被引用 108 件2013 年: 被引用 129 件2014 年: 被引用 132 件2015 年: 被引用 155 件2016 年: 被引用 206 件2017 年: 被引用 214 件2018 年: 被引用 272 件2019 年: 被引用 938 件2020 年: 被引用 1,319 件2021 年: 被引用 1,514 件2022 年: 被引用 1,401 件2023 年: 被引用 1,126 件2024 年: 被引用 1,867 件2025 年: 被引用 1,028 件2026 年: 被引用 40 件1996〜1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,652 件、この内訳の 19.1%中国: 引用元論文 1,637 件、この内訳の 11.8%イギリス: 引用元論文 1,214 件、この内訳の 8.7%イタリア: 引用元論文 803 件、この内訳の 5.8%ドイツ: 引用元論文 703 件、この内訳の 5.1%スペイン: 引用元論文 526 件、この内訳の 3.8%フランス: 引用元論文 480 件、この内訳の 3.5%日本: 引用元論文 364 件、この内訳の 2.6%カナダ: 引用元論文 362 件、この内訳の 2.6%オーストラリア: 引用元論文 336 件、この内訳の 2.4%インド: 引用元論文 305 件、この内訳の 2.2%オランダ: 引用元論文 290 件、この内訳の 2.1%
0%19.1%その他 30.3%

分野

  • Medicine73.4%
  • Pharmacology, Toxicology and Pharmaceutics14.1%
  • Biochemistry, Genetics and Molecular Biology7.5%
  • Immunology and Microbiology1.1%
  • Computer Science0.8%
  • Engineering0.5%
  • その他2.6%

トピック

  • Liver Disease Diagnosis and Treatment17.8%
  • Liver Disease and Transplantation5.5%
  • Drug-Induced Hepatotoxicity and Protection4.7%
  • Diet, Metabolism, and Disease4.5%
  • Liver Diseases and Immunity3%
  • Pharmacogenetics and Drug Metabolism2.9%
  • その他61.6%

共著者

全論文

検索で開く
  1. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

    著者: , , , , , , , , , , , , , , , - The Lancet 2015 被引用: 2,125

  2. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Luna Zaru, Leigh MacConell, Reshma Shringarpure, Stephen A. Harrison, Arun J. Sanyal, Manal F. Abdelmalek, Gary A. Abrams, Humberto Aguilar, Aijaz Ahmed, Elmar Aigner, Guruprasad P. Aithal, Aftab Ala, William Alazawi, Agustı́n Albillos, Michael Allison, Sfa Al-Shamma, Raúl J. Andrade, Pietro Andreoné, M. Angélico, Victor Ankoma‐Sey, Quentin M. Anstee, Rodolphe Anty, Víctor Araya, Juan Ignacio Arenas Ruiz, Perttu Arkkila, Marty Arora, Tarik Asselah, Jennifer Au, Oyekoya T. Ayonrinde, Robert J. Bailey, Maya Balakrishnan, Kiran Bambha, Meena B. Bansal, Sidney Barritt, John Bate, Jorge Beato, Susanne Beckebaum, Jaideep Behari, Pablo Bellot, Ziv Ben Ari, Michael Bennett, Marina Berenguer, Benedetta Terziroli Beretta‐Piccoli, Thomas Berg, Maurizio Bonacini, Lucía Bonet, Brian B. Borg, Marc Bourlière, Jérôme Boursier, William D. Bowman, David Bradley, Marija Branković, Marius Braun, Jean-Pierre Bronowicki, Savino Bruno, Elisabetta Bugianesi, Cindy X. Cai, Amy Calderon, José Luis Calleja Panero, Elizabeth J. Carey, Michal Carmiel, J.A. Carrión, Matthew C. Cave, Cristina Chagas, Tawfik N. Chami, Alan K. Chang, Allan Coates, Jeremy Cobbold, Charlote Costentin, Kathleen E. Corey ほか 288 名 - The Lancet 2019 被引用: 1,213

  3. Drug-induced liver injury

    著者: , , , , , , , , , , - Nature Reviews Disease Primers 2019 被引用: 801

  4. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Won Kim, Myoung Seok Lee, Johannes Wiegand, Thomas Karlas, Yusuf Yılmaz, Guruprasad P. Aithal, Naaventhan Palaniyappan, Christophe Cassinotto, Sandeep Aggarwal, Harshit Garg, Geraldine Ooi, Atsushi Nakajima, Masato Yoneda, Marianne Ziol, Nathalie Barget, Andreas Geier, Theresa Tuthill, M. Julia Brosnan, Quentin M. Anstee, Stefan Neubauer, Stephen A. Harrison, Patrick M. Bossuyt, Michael Pavlides - Gut 2021 被引用: 485

  5. EASL Clinical Practice Guidelines: Drug-induced liver injury

    著者: , , , , , , - Journal of Hepatology 2019 被引用: 1,130

  6. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2020 被引用: 514

  7. Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guruprasad P. Aithal, Jörn M. Schattenberg, Elisabetta Bugianesi, Manuel Romero‐Gómez, Vlad Ratziu, Quentin M. Anstee, Patrick M. Bossuyt - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 196

  8. Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anja Geerts, Christophe Moreno, Ulrich Beuers, Peter R. Galle, U. Spengler, Elisabetta Bugianesi, Antonio Craxı̀, M. Angélico, Silvia Fargion, M Voiculescu, Liliana Gheorghe, Liliana Preoțescu, Juan Caballería, Raúl J. Andrade, Javier Crespo, J.L. Callera, Aftab Ala, Guruprasad P. Aithal, George Abouda, Velimir A. Luketic, Mao-Yu Huang, Stuart C. Gordon, Paul J. Pockros, Fred Poordad, Nathan J. Shores, Martin Moehlen, Kiran Bambha, Virginia Clark, Sanjaya K. Satapathy, Samir Parekh, R.K. Reddy, Muhammad Y. Sheikh, Gyöngyi Szabó, John M. Vierling, Timothy E. Foster, Guillermo E. Umpierrez, Chih‐Jen Chang, Terry Box, Juan F. Gallegos‐Orozco - Gastroenterology 2016 被引用: 1,014

  9. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Vlad Ratziu, Karine Clément, Raluca Pais, Detlef Schuppan, Jörn M. Schattenberg, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas, Evangelia Petsalaki, Matej Orešič, Tuulia Hyötyläinen, Aiden McGlinchey, José M. Mato, Óscar Millet, Jean‐François Dufour, Annalisa Berzigotti, Michael Pavlides, Stephen A. Harrison, Stefan Neubauer, Jeremy Cobbold, Ferenc E. Mózes, Salma Akhtar, Rajarshi Banerjee, Matt Kelly, Elizabeth Shumbayawonda, Andrea Dennis, Charlotte Erpicum, Manuel Romero‐Gómez, Emilio Gómez-González, Javier Ampuero, Javier Castell, Rocío Gallego‐Durán, Isabel Fernández-Lizaranzu, Rocío Montero‐Vallejo, M.A. Karsdal, Elisabeth Erhardtsen, Daniel Guldager Kring Rasmussen, Diana Julie Leeming, Mette Juul Fisker, Antonia Sinisi, Kishwar Musa, Fay Betsou, Estelle Sandt, Manuela Tonini, Elisabetta Bugianesi, Chiara Rosso, Angelo Armandi, Fabio Marra, Amalia Gastaldelli, Gianluca Svegliati, Jérôme Boursier, Sven Francque, Luisa Vonghia, Mattias Ekstedt, Stergios Kechagias, Hannele Yki‐Järvinen, Panu K. Luukkonen, Saskia W. C. van Mil, George Papatheodoridis, Helena Cortez‐Pinto, Luca Valenti, Salvatore Petta, Luca Miele, Andreas Geier ほか 35 名 - Journal of Hepatology 2021 被引用: 353

  10. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hannes Hagström, Camilla Akbari, Masashi Hirooka, Wah‐Kheong Chan, Sanjiv Mahadeva, Ruveena Bhavani Rajaram, Ming‐Hua Zheng, Jacob George, Mohammed Eslam, Salvatore Petta, Grazia Pennisi, Mauro Viganò, Sofia Ridolfo, Guruprasad P. Aithal, Naaventhan Palaniyappan, Dae Ho Lee, Mattias Ekstedt, Patrik Nasr, Christophe Cassinotto, Victor de Lédinghen, Annalisa Berzigotti, Yuly P. Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier‐Poizat, Andreas Geier, Miljen Martić, Theresa Tuthill, Quentin M. Anstee, Stephen A. Harrison, Patrick M. Bossuyt, Michael Pavlides, Quentin M. Anstee, Ann K. Daly, Olivier Govaere, Simon Cockell, Dina Tiniakos, Pierre Bédossa, Alastair D. Burt, Fiona Oakley, Heather J. Cordell, Christopher P. Day, Kristy Wonders, Paolo Missier, Matthew McTeer, Luke Vale, Yemi Oluboyede, Matt Breckons, Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Joanne Verheij, Vlad Ratziu, Karine Clément, Rafael Patiño‐Navarrete, Raluca Pais, Valérie Paradis, Detlef Schuppan, Jörn M. Schattenberg, Rambabu Surabattula, Sudha Rani Myneni, Beate K. Straub, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas ほか 130 名 - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 187

  11. Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study

    著者: , , , , , , , , , , , , - Hepatology 2020 被引用: 361

  12. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2019 被引用: 612

  13. Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population

    著者: , , , , , , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2021 被引用: 276

  14. Case Definition and Phenotype Standardization in Drug-Induced Liver Injury

    著者: , , , , , , , , , , , - Clinical Pharmacology & Therapeutics 2011 被引用: 1,017

  15. A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2017 被引用: 658

  16. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , - Nature Communications 2014 被引用: 617

  17. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Baki Topal, Karine Clément, Stefano Romeo, Vlad Ratziu, Tania Roskams, Ann K. Daly, Quentin M. Anstee, Matthias Trost, Anetta Härtlová - Journal of Hepatology 2021 被引用: 160

  18. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anna Licata, M. Isabel Lucena, Giorgina Mieli‐Vergani, Diego Vergani, Einar S. Björnsson - Journal of Hepatology 2023 被引用: 150

  19. Guidelines on the management of ascites in cirrhosis

    著者: , , , , , , , , , , , - Gut 2020 被引用: 665

  20. Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines

    著者: , , , , , , , , , , , - Hepatology International 2021 被引用: 161

  21. Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis

    著者: , , , , , , , , , - Gastroenterology 2008 被引用: 705

  22. ADAPT: An Algorithm Incorporating PRO‐C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis

    著者: , , , , , , , , , , , , , , , , , - Hepatology 2018 被引用: 257

  23. A revised electronic version of RUCAM for the diagnosis of DILI

    著者: , , , , , , , , , , - Hepatology 2022 被引用: 140

  24. Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management

    著者: , - Journal of Clinical and Experimental Hepatology 2012 被引用: 506